- Practice Area
- Administrative Law
- Admiralty & Maritime Law
- Advertising Law
- Alternative Dispute Resolution
- AmLaw 200 Blogs
- Antitrust Law
- Civil Rights & Privacy Law
- Consumer Law
- Corporate & Commercial Litigation
- Criminal Law
- Divorce & Family Law
- Education Law
- Election Law & Political Commentary
- Electronic Discovery
- Employment & Labor Law
- Environmental Law
- General Counsel Blogs
- Immigration Law
- Insurance Law
- Intellectual Property Law
- International Law
- Judiciary Law
- Media, Entertainment & Sports Law
- Law Firm Management & Legal Marketing
- Personal Injury & Medical Law
- Probate & Estate Planning
- Real Estate & Construction Law
- Tax & Financial Law
- Whistleblower Law
- Workers' Compensation
- Law School
An associate with McGuire Woods LLP, Amber Walsh has focused her practice on corporate healthcare transactional work and regulatory matters. Based out of the firm’s Chicago offices, has represented various types of healthcare providers including hospitals, health systems, dialysis facilities, multi and single specialty medical practices, specialty hospitals, ambulatory surgery centers, and a variety of healthcare industry entrepreneurs. Ms. Walsh, a contributor to the firm’s blog The Healthcare Investor, assists her clients n sales and acquisitions, joint ventures, general corporate matters, contracting, securities, and regulatory matters.
Information and the means of communicating that data in a cost-effective, secure, user-friendly and legally compliant manner is critical in any industry. Targeted healthcare-related IT, information technology specifically designated to improve patient care and advance quality and efficiency...
As we round out our series on private equity investing in dialysis, we note an emergence in overseas dialysis investing by U.S. investors. Our blog typically focuses on U.S. investing but can’t help but note the interest in overseas activity. In particular, dialysis centers...
Part II of our series on private equity investing in dialysis discusses other dialysis companies backed by private equity and highlights some key considerations for investors and companies. Funded in 2000, U.S. Renal Care (USRC), is another dialysis company (generally considered an...
Private equity investors have been active in the dialysis sector for decades. In Part I of this series on dialysis investments, we describe the recent emergence of three companies with private equity backing. First, in 2010 Bain Capital Ventures and KRG Capital invested in Liberty...
McGuireWoods to Host 9th Annual Healthcare & Life Sciences Private Equity & Finance Conference February 22-23
We have recently published the final agenda for our upcoming 9th Annual Healthcare & Life Sciences Private Equity & Finance Conference to be held on February 22-23 at The Ritz-Carlton in Chicago. We are again co-hosting with McGladrey and are pleased to have another outstanding group...